Pale Fire Capital SE Has $277,000 Stock Position in Liquidia Corporation $LQDA

Pale Fire Capital SE trimmed its position in Liquidia Corporation (NASDAQ:LQDA) by 99.1% in the second quarter, HoldingsChannel.com reports. The firm owned 3,479 shares of the company’s stock after selling 384,898 shares during the period. Pale Fire Capital SE’s holdings in Liquidia were worth $277,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of LQDA. TCG Crossover Management LLC bought a new stake in Liquidia in the 3rd quarter valued at $38,887,000. MPM Bioimpact LLC boosted its position in shares of Liquidia by 600.4% during the 4th quarter. MPM Bioimpact LLC now owns 1,400,869 shares of the company’s stock valued at $48,316,000 after acquiring an additional 1,200,869 shares in the last quarter. Voloridge Investment Management LLC bought a new stake in Liquidia in the third quarter valued at about $12,571,000. Bank of New York Mellon Corp acquired a new position in Liquidia in the second quarter worth about $29,694,000. Finally, Bank of America Corp DE lifted its stake in Liquidia by 18.7% during the first quarter. Bank of America Corp DE now owns 2,287,792 shares of the company’s stock worth $86,341,000 after purchasing an additional 360,372 shares during the period. Institutional investors and hedge funds own 64.54% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on LQDA. HC Wainwright set a $36.00 target price on Liquidia in a report on Friday, July 24th. Lifesci Capital lowered Liquidia from an “outperform” rating to a “hold” rating and set a $90.00 price objective for the company. in a research note on Wednesday, August 12th. Weiss Ratings reissued a “sell (d-)” rating on shares of Liquidia in a report on Friday, July 17th. Needham & Company LLC boosted their target price on shares of Liquidia from $70.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, August 12th. Finally, Wall Street Zen lowered shares of Liquidia from a “strong-buy” rating to a “buy” rating in a report on Saturday, June 27th. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, three have given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $98.08.

Insider Activity

In other Liquidia news, Director Stephen M. Bloch sold 242,269 shares of the company’s stock in a transaction on Thursday, June 11th. The stock was sold at an average price of $70.43, for a total transaction of $17,063,005.67. Following the transaction, the director owned 1,176,184 shares of the company’s stock, valued at approximately $82,838,639.12. This represents a 17.08% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jason Adair sold 73,631 shares of the stock in a transaction on Friday, August 21st. The shares were sold at an average price of $69.09, for a total value of $5,087,165.79. Following the completion of the transaction, the insider owned 174,606 shares in the company, valued at $12,063,528.54. The trade was a 29.66% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 1,541,274 shares of company stock worth $111,545,379. 25.60% of the stock is owned by corporate insiders.

Liquidia Stock Up 4.1%

NASDAQ LQDA opened at $69.68 on Thursday. The stock’s 50 day simple moving average is $78.86 and its 200 day simple moving average is $57.83. Liquidia Corporation has a one year low of $21.15 and a one year high of $93.61. The firm has a market cap of $6.24 billion, a PE ratio of 50.86 and a beta of 0.53. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.31 and a quick ratio of 2.12.

Liquidia (NASDAQ:LQDA) last posted its quarterly earnings data on Wednesday, August 12th. The company reported $0.74 EPS for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.02). The business had revenue of $171.68 million during the quarter, compared to analyst estimates of $168.48 million. Liquidia had a return on equity of 149.65% and a net margin of 30.74%.Liquidia’s revenue for the quarter was up 1842.1% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.49) EPS. As a group, sell-side analysts forecast that Liquidia Corporation will post 2.57 earnings per share for the current fiscal year.

About Liquidia

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).